Stay updated on ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial

Sign up to get notified when there's something new on the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Footer/site metadata updated: Revision v3.3.3 added; HHS Vulnerability Disclosure link removed and Revision v3.3.2 removed, with no impact on study content or user actions on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T09:13:50.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page shows an updated revision from v3.3.1 to v3.3.2, indicating a minor update to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:26:02.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Added revision label v3.3.1 and removed revision label v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:32:36.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Funding-status notice at the bottom of the page was removed. The core study content, including objectives, eligibility criteria, and outcome measures, remains unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T06:40:00.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    No significant changes detected between the two page states; only minor visual differences are observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T01:12:52.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    3%
    Check dated 2025-10-05T10:16:13.000Z thumbnail image

Stay in the know with updates to ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page.